 PETAH TIKVA, Israel, Feb. 23, 2021 GLOBE NEWSWIRE -- PolyPid Ltd. Nasdaq: PYPD, a late-stage biopharmaceutical company aiming to improve surgical outcomes through locally administered, controlled, extended-release therapeutics, today announced that it will present at the Raymond James 42nd Annual Institutional Investors Conference and the Barclays Global Healthcare Conference in March. The Company will also participate in one-on-one investor meetings during both events. 